Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
Base Year
Historical Period
Forecast Period
Germany held the top of the four markets we track for the doxepin HCl through the first half of the year 2026 (H1 2026), with Q2 closing at a value of USD 252/KG, up 1.6% from the USD 248 in Q1. Worldwide, the average firmed to a value of USD 215/KG in Q2 2026, a gain of just a 1.4% percent over the Q1 figure of USD 212, as the API buyers held their procurement steady.
The doxepin HCl is an active pharmaceutical ingredient, made from the dibenzoxepinone intermediate and the hydrochloric acid. It is a tricyclic compound used in the antidepressant and the antihistamine formulations, including the topical anti-itch products. It is a low-volume specialty API, so the price sits high and moves in a narrow band compared with the bulk chemicals.
Two things move the doxepin HCl price the most: the dibenzoxepinone intermediate cost, and the regulated, low-volume API demand cycle. For the second half of 2026 (H2 2026), a range of an amount of USD 210 to 230/KG looks likely worldwide, supported by the steady formulation offtake and the firm intermediate costs.
Supply looks steady through the H2 2026, with the dibenzoxepinone intermediate cost and the regulated demand setting the direction. The formulation buyers held their procurement steady through the H1, and that looks set to hold. China and the India keep the lower-cost API supply, while the United States and the Germany track higher on the regulated sourcing and the freight.
The market sits set for a firm and a narrow move, the way the specialty APIs usually trade. The bigger question for the buyers is how the intermediate cost moves, since that carries most of the finished-API price for a low-volume compound like this.
What could push the prices higher? A dibenzoxepinone intermediate spike, or a tightening of the GMP-approved supply. What could pull them lower? Softer formulation demand, or added low-cost API capacity in the Asia.
| Region | 2026 Price Range (USD/KG) | Outlook |
| Global Average | 210 - 230 | Steady formulation demand, intermediate-led |
| China | 175 - 190 | Large API base keeps China a low-cost source |
| India | 183 - 200 | Competitive API supply and export pull |
| United States | 240 - 262 | Regulated sourcing commands a premium |
| Germany | 248 - 270 | Regulated pharma demand holds the top |
China firmed a value of 1.7% to the USD 178/KG, the producers passing through a little of the firmer dibenzoxepinone intermediate cost. The large API base kept the China among the lower-cost sources of the four.
Why did the price of Doxepin HCl change in Q2 2026 in China?
The firmer dibenzoxepinone intermediate cost lifted the offers, though the ample API base kept the gain small.
India moved up a value of 1.6% to the USD 186/KG, the export and the domestic formulation demand steady and the intermediate cost firming. The competitive API supply kept India close to the China on the price.
Why did the price of Doxepin HCl change in Q2 2026 in India?
The steady formulation demand met the firmer intermediate cost, with the competitive supply holding the move measured.
The United States firmed a value of 1.7% to the USD 244/KG, the regulated formulation demand dependable while the sourcing and the compliance costs held firm. That kept the United States among the priciest of the four.
Why did the price of Doxepin HCl change in Q2 2026 in United States?
The dependable regulated demand met the firm sourcing and the compliance costs through the quarter.
Germany gained a value of 1.6% to the USD 252/KG, its regulated pharmaceutical demand holding firm. The compliance and the import-linked costs kept the German prices at the top of the four.
Why did the price of Doxepin HCl change in Q2 2026 in Germany?
The regulated demand held, and the compliance and the import-linked costs firmed alongside it.
China firmed a value of 2.3% to the USD 175/KG, the intermediate cost turning up as the year opened and the formulation buyers refilling the light inventories.
Why did the price of Doxepin HCl change in Q1 2026 in China?
The firmer intermediate cost met the formulation restocking as the year opened.
India rose a value of 2.2% to the USD 183/KG, the export API demand recovering with the new year and the intermediate cost firming.
Why did the price of Doxepin HCl change in Q1 2026 in India?
The recovering export API demand met the firmer intermediate cost into the new year.
The United States firmed a value of 2.1% to the USD 240/KG, the regulated buyers restocking and the sourcing costs lifting the delivered value.
Why did the price of Doxepin HCl change in Q1 2026 in United States?
The regulated buyers restocked, and the sourcing costs lifted the delivered value.
Germany gained a value of 2.1% to the USD 248/KG, the regulated demand steady and the compliance-linked costs firming into the new year.
Why did the price of Doxepin HCl change in Q1 2026 in Germany?
The steady regulated demand met the firmer compliance-linked costs into the new year.
The global average held a firm and a narrow path across the window, moving from a value of USD 204/KG in the Q1 2025 to the USD 215 by the Q2 2026, a net gain of about 5.4%. The low-volume specialty nature of the compound kept the swings small, with the dibenzoxepinone intermediate cost setting most of the direction across the quarters.
| Quarter | Price (USD/KG) | QoQ Change | Direction |
| Q2 2026 | 215 | +1.4% | ↑ Rising |
| Q1 2026 | 212 | +2.4% | ↑ Rising |
| Q4 2025 | 207 | +1.0% | ↑ Rising |
| Q3 2025 | 205 | -0.5% | ↓ Falling |
| Q2 2025 | 206 | +1.0% | ↑ Rising |
| Q1 2025 | 204 | - | - Stable |
| Q3 2026 | In Progress | - | - In Progress |
The year 2025 ran firm and quiet for the doxepin HCl. The global average moved from a value of USD 204/KG in the Q1 to the USD 207 by the Q4, a gain of about 1.5% across the year. The low-volume specialty demand held the market steady, with only a shallow Q3 dip, and the dibenzoxepinone intermediate cost set the pace throughout.
Chinese prices moved from a value of USD 168/KG in the Q1 2025 to the USD 171 by the Q4, up about 1.8%. The steady API demand and the firm intermediate cost held the market, and China stayed among the lower-cost sources of the four all year.
Indian prices firmed from a value of USD 176/KG in the Q1 to the USD 179 by the Q4, a gain of about 1.7%. The export and the domestic formulation demand held steady, and the competitive API supply kept India close to the China.
The United States prices moved from a value of USD 232/KG in the Q1 to the USD 235 by the Q4, up about 1.3%. The regulated formulation demand kept the market firm, and the United States held among the priciest of the four all year.
German prices firmed from a value of USD 240/KG in the Q1 to the USD 243 by the Q4, a gain of about 1.3%. The regulated pharma demand kept the market steady, and the compliance and the import costs held Germany the dearest of the four.
Expert Market Research: Your Source for Real-Time Doxepin HCl Price Intelligence
We keep a continuous watch on the doxepin HCl prices wherever it is produced or consumed at scale, tracing the causation through the dibenzoxepinone intermediate economics and the regulated, low-volume API demand. Our analysts track all four of the markets on a monthly basis, so the figures reflect the most current data at the time of the publication. Contact Expert Market Research today for the Doxepin HCl pricing data, the bespoke market analysis, and the strategic procurement advisory.
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
The doxepin HCl is a tricyclic active pharmaceutical ingredient. It goes into the antidepressant and the antihistamine formulations, including the topical anti-itch products, with the USP grade carrying most of the regulated volume.
In Q2 2026, it averaged a value of USD 178/KG in China, USD 244/KG in the US, USD 252/KG in Germany, and USD 186/KG in India, on a delivered basis. Germany sat at the top and China priced lowest.
The global average moved from a value of USD 204/KG in the Q1 2025 to the USD 207 by the Q4, a gain of about 1.5%. The low-volume specialty demand held the market steady, with only a shallow Q3 dip.
The steady regulated demand and the firm dibenzoxepinone intermediate cost held the market in a narrow band, the way the specialty APIs usually trade.
We expect a global average in a range of an amount of USD 210 to 230/KG for the H2 2026, resting on the steady formulation offtake and the intermediate costs staying near their current range.
Germany sits at the top on the regulated pharma demand and the compliance-linked costs. The United States holds a firm second on its regulated sourcing. India offers competitive API supply, and China prices lowest on its large pharmaceutical base.
The dibenzoxepinone intermediate cost matters most for a low-volume API like this, followed by the regulated demand cycle and the GMP-approved supply availability.
China and the India hold the largest API production capacity on their pharmaceutical bases, with the United States and the Germany hosting the regulated high-value demand. The regulated-sourcing regions carry a premium over the Asian API offers.
Monthly. Need something more current? Our team is available directly.
The quarterly trends and the forecasts help time the API contract talks around the intermediate cost cycles, which matters most for the buyers weighing the fixed-price and the index-linked supply for a specialty compound.
Basic Report -
One Time
Basic Report -
Annual Subscription
Detailed Report -
One Time
Detailed Report -
Annual Subscription
Basic Report -
One Time
USD 799
tax inclusive*
Basic Report -
Annual Subscription
USD 3,499
tax inclusive*
Detailed Report -
One Time
USD 4,299
tax inclusive*
Detailed Report -
Annual Subscription
USD 7,999
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Strategic Solutions for Informed Decision-Making
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.